Pre- and post-transplant monitoring of granzyme B enzyme-linked immunosorbent spot assay in pediatric liver recipients

Transplant Immunology

Volumn 19, Issue 3-4, 2008, Pages 215-219

  Truong, Dinh Quang ^a,b   Cornet, Anne ^a   Wieërs, Grégoire ^a   Robert, Annie ^c   Reding, Raymond ^a   Latinne, Dominique ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b University Medical Center   (Viet Nam)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Cytotoxic lymphocyte; Enzyme linked immunosorbent spot; Granzyme B; Pediatric liver transplantation; Rejection

Indexed keywords

GRANZYME B;

ACUTE GRAFT REJECTION; ADOLESCENT; ALLOIMMUNITY; ARTICLE; CELL KINETICS; CHILD; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; INFANT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; PATIENT MONITORING; PERIPHERAL BLOOD MONONUCLEAR CELL; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

ADOLESCENT; ANIMALS; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; GRANZYMES; HLA ANTIGENS; HUMANS; INFANT; LEUKOCYTES, MONONUCLEAR; LIVER TRANSPLANTATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MONITORING, IMMUNOLOGIC; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 48149086729     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2008.06.001     Document Type: Article

References (38)

1. Newell K.A. Transplant tolerance: converging on a moving target. Transplantation 81 (2006) 1-6
2. Soulillou J.P., and Giral M. Controlling the incidence of infection and malignancy by modifying immunosuppression. Transplantation 72 12 suppl (2001) S84
3. Galbaraith C.A., and Hathaway D. Longterm affects of transplantation on quality of life. Transplantation 77 9 suppl (2004) S84
4. Newell K.A., and Larsen C.P. Tolerance assay: measuring the unknown. Transplantation 81 (2006) 1503-1509
5. Reding R., Gras J., Truong D.Q., Wieers G., and Latinne D. The immunological monitoring of alloreactive responses in liver transplant recipients: a review. Liver Transplant 12 (2006) 373-383
6. Trinchieri G., and Perussia B. Human natural killer cells: biologic and pathologic aspects. Lab invest 50 (1984) 489-513
7. Rininsland F.H., Helms T., Asaad R.J., Boehm B.O., and Tary-Lehmann M. Granzyme B ELISPOT assay for ex vivo measurements of T cell immunity. J Immunol Methods 240 (2000) 143-155
8. Finn O.J., and Lotze M.T. A decade in the life of tumor immunology. Clin Cancer Res 7 (2001) 759s-760s
9. Shafer-Weaver K.A., Sayers T., Kuhns D.B., Strobl S.L., Burkett M.W., Baseler M., et al. Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assay. J Transnatl Med 2 (2004) 31
10. Bendjelloul F., Desin T.S., and Shoker A.S. Donor non-specific IFN-γ production by primed alloreactive cells as a potential screening test to predict the alloimmune response. Transpl Immunol 12 (2004) 167-176
11. Van Besouw N.M., Zuijderwijk J.M., de Kuiper P., Ijzermans J.N., Weimar W., and van der Mast B.J. The granzyme B and interferon-gamma enzyme-linked immunospot assay as alternatives for cytotoxic T-lymphocyte precursor frequency after renal transplantation. Transplantation 79 (2005) 1062-1066
12. Lakkis F.G., and Sayegh M.H. Memory T cells: a hurdle to immunologic tolerance. J Am Soc Nephrol 14 (2003) 2402-2410
13. Reding R., Gras J., Sokal E., Otte J.B., and Davies H.F. Steroid-free liver transplantation in children. Lancet 362 (2003) 2068-2070
14. Nickel P., Presber F., Bold G., Biti D., Schönemann C., Tullius S.G., et al. Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal-transplant recipients. Transplantation 78 (2004) 1640-1646
15. Augustine J.J., Siu D.S., Clemente M.J., Schulak J.A., Heeger P.S., and Hricik D.E. Pre-transplant IFN-gamma ELISPOT are associated with post-transplant renal function in African American renal transplant recipients. Am J Transplant 5 (2005) 1971-1975
16. Näther B.J., Nickel P., Bold G., Presber F., Schönemann C., Pratschke J., et al. Modified ELISPOT technique-highly significant inverse correlation of post-Tx donor-reactive IFN-gamma-producing cell frequencies with 6 and 12 months graft function in kidney transplant recipients. Transpl Immunol 16 (2006) 232-237
17. Bellisola G., Tridente G., Nacchia F., Fior F., and Boschiero L. Monitoring of cellular immunity by interferon-gamma enzyme-linked immunosorbent spot assay in kidney allograft recipients: preliminary results of a longitudinal study. Transplant Proc 38 (2006) 1014-1017
18. Heeger P.S., Greenspan N.S., Kuhlenschmidt S., Dejelo C., Hricik D.E., Schulak J.A., et al. Pretransplant frequency of donor specific, IFN-γ producing lymphocytes is a manifestation of immunologic memory and correlated with the risk posttransplant rejection episodes. J Immunol 163 (1999) 2267-2275
19. Gebauer B.S., Hricik D.E., Atallah A., Bryan K., Riley J., Tary-Lehmann M., et al. Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool. Am J Transplant (2002) 857-866
20. D.E. Hricik, V. Rodriguez, J. Riley, K. Bryan, M. Tary-Lehmann, N. Greenspan, et al., Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients. 2003;7:878-884.
21. Najafian N., Salama A.D., Fedoseyeva E.V., Benichou G., and Sayegh M.H. Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients. J Am Soc Nephrol 13 (2002) 252-259
22. Weston S.J., Leistikow R.L., Reddy K.R., Torres M., Wertheimer A.M., Lewinsohn D.M., et al. et al.Reconstitution of hepatitis C virus-specific T-cell mediated immunity after liver transplantation. Hepatology 41 (2005) 72-81
23. Graziotto R., Del Prete D., Rigotti P., Anglani F., Baldan N., Furian L., et al. Perforin, granzyme B, and fas ligand for molecular diagnosis of acute renal-allograft rejection: analyses on serial biopsies suggest methodological issues. Transplantation 81 (2006) 1125-1132
24. Carstens J., Markussen N., and Madsen M. The granule exocytosis and Fas/FasLigand pathways at the time of transplantation and during borderline and acute rejection of human renal allografts. Transplant Proc 37 (2005) 3294-3297
25. Kuijf M.L., Kwekkeboom J., Kuijpers M.A., Willems M., Zondervan P.E., Niesters H.G., et al. Granzyme expression in fine-needle aspirates from liver allografts is increased during acute rejection. Liver Transplant 8 (2002) 952-956
26. Krams S.M., Villanueva J.C., Quinn M.B., and Martinez O.M. Expression of the cytotoxic T cell mediator granzyme B during liver allograft rejection. Transpl Immunol 3 (1995) 162-166
27. D'Errico A., Corti B., Pinna A.D., Altimari A., Gruppioni E., Gabusi E., et al. Granzyme B and perforin as predictive markers for acute rejection in human intestinal transplantation. Transplant Proc 35 (2003) 3061-3065
28. Veale J.L., Liang L.W., Zhang Q., Gjertson D.W., Du Z., Bloomquist E.W., et al. Noninvasive diagnosis of cellular and antibody-mediated rejection by perforin and granzyme B in renal allografts. Hum Immunol 67 (2006) 777-786
29. Shin G.T., Kim S.J., Lee T.S., Oh C.K., and Kim H. Gene expression of perforin by peripheral blood lymphocytes as a marker of acute rejection. Nephron Clin Pract 100 (2005) c63-c70
30. Cashion A.K., Sabek O.M., Driscoll C.J., Gaber L.W., and Gaber A.O. Serial peripheral blood cytotoxic lymphocyte gene expression measurements for prediction of pancreas transplant rejection. Transplant Proc 38 (2006) 3676-3677
31. Clément M.V., Legros-Maïda S., Israël-Biet D., Carnot F., Soulié A., Reynaud P., et al. Perforin and granzyme B expression is associated with severe acute rejection. Evidence for in situ localization in alveolar lymphocytes of lung-transplanted patients. Transplantation 57 (1994) 322-326
32. Li B., Hartono C., Ding R., Sharma V.K., Ramaswamy R., Qian B., et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 344 (2001) 1006-1007
33. K. Shafer-Weaver, S. Rosenberg, S. Strobl, W. Gregory Alvord, M. Baseler, A. Malyguine, Application of the granzyme B ELISPOT assay for monitoring cancer vaccine trials. J Immunother (1997) 2006;29:328-335.
34. Gerrits J.H., van de Wetering J., Ijzermans J.N., Weimar W., and van Besouw N.M. Granzyme B ELISPOT assay determines the cytotoxic T lymphocyte precursor frequency after HLA-identical living-related kidney transplantation. Transplant Proc 37 (2005) 752-754
35. Ogura Y., Martinez O.M., Villanueva J.C., Tait J.F., Strauss H.W., Higgins J.P., et al. Apoptosis and allograft rejection in the absence of CD8+ T cells. Transplantation 71 (2003) 1827-1834
36. Reding R., and Davies H.F. Revisiting liver transplant immunology: from the concept of immune engagement to the dualistic pathway paradigm. Liver Transplant 10 (2004) 1081-1086
37. Navarro V., Herrine S., Katopes C., Colombe B., and Spain C.V. The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: an analysis of the OPTN database. Liver Transplant 12 (2006) 652-658
38. Tinckam K.J., and Sayegh M.H. Transplantation tolerance in pediatric recipients: lessons and challenges. Pediatr Transplant 9 (2005) 17-27